LKT Labs

Biochemicals for Life Science Research

Epothilone A

Epothilone A

Product ID E6256
Cas No. 152044-53-6
Purity ≥95%
Product Unit SizeCostQuantityStock
1 mg $67.40 In stock
5 mg $119.90 In stock
10 mg $209.80 In stock
25 mg $441.90 In stock
Bulk Quote

Quicklinks

Description

Epothilone is an anticancer chemotherapeutic that acts as an anti-mitotic compound; it binds the taxane pocket of β-tubulin, using side chains to induce formation of a short helix and preventing microtubule depolymerization. Epothilone displays activity against lung cancer and prostate cancer in clinical trials and may show benefit in treatment of neurodegenerative diseases such as Alzheimer’s disease. Typically, the degree of chemotherapeutic activity of the three epothilone subtypes follows the alphabet, where Epo A> Epo B> Epo D.

Product Info

Cas No.

152044-53-6
Purity

≥95%
Formula

C26H39NO6S
Formula Wt.

493.66
IUPAC Name

(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-5,7,9, 9-tetramethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-13, 17-dioxabicyclo[14.1.0]heptadecane-8,12-dione
Solubility

Soluble in DMSO (≥99mg/mL) and Ethanol (≥99mg/mL). Practically insoluble in Water (<1mg/mL).

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

E6256 MSDS PDF
Info Sheet

E6256 Info Sheet PDF

References

Prota AE, Bargsten K, Zurwerra D, et al. Molecular mechanism of action of microtubule-stabilizing anticancer agents. Science. 2013 Feb 1;339(6119):587-90. PMID: 23287720.

Entwistle RA, Rizk RS, Cheng DM, et al. Differentiating between models of epothilone binding to microtubules using tubulin mutagenesis, cytotoxicity, and molecular modeling. ChemMedChem. 2012 Sep;7(9):1580-6. PMID: 22807375.

Edelman MJ, Shvartsbeyn M. Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance. Clin Lung Cancer. 2012 May;13(3):171-80. PMID: 22133291

Kelly WK. Epothilones in prostate cancer. Urol Oncol. 2011 Jul-Aug;29(4):358-65. PMID: 19914096.

Rusinska-Roszak D, Tatka H, Pawlak R, et al. Extended and clustered conformers of epothilone A. J Phys Chem B. 2011 Apr 7;115(13):3698-707. PMID: 21405036.

Lee JJ, Kelly WK. Epothilones: tubulin polymerization as a novel target for prostate cancer therapy. Nat Clin Pract Oncol. 2009 Feb;6(2):85-92. PMID: 19048010.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C0044

    CAL101

    p110δ PI3K inhibitor.
    ≥98%
  • L1786

    Levofloxacin Hydrochloride Monohydrate

    Fluoroquinolone, S-(-) isomer of ofloxacin; topois...
    ≥90%
  • X1854

    p-Xyleneselenocyanate

    Synthetic derivative of selenocyanate.
    ≥99%
  • A1371

    Adrenorphin

    Endogenous opioid peptide; μOR and κOR agonist.
    ≥95%
  • C6982

    Crustacean Cardioactive Peptide

    Neuropeptide hormone found in arthropods.
    ≥95%
  • S1607

    Secretin, rat

    Endogenous peptide hormone, involved in feeding be...
    ≥95%
  • A7203

    AS-703026

    MEK1/2 inhibitor.
    ≥98%
  • D1850

    Demethoxycurcumin

    Curcumin derivative; AMPK activator, STAT3 and eIF...
    ≥98%
  • T698579

    Tropodithietic Acid

    Produced by various marine proteobacteria
    ≥99%
  • I5208

    INCB-28060

    c-MET inhibitor.
    ≥98%
  • R0020

    RAF265

    B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit, S...
    ≥98%
  • D0262

    Dapiprazole Hydrochloride

    α1-Adrenergic antagonist.
    ≥98%
  • A2412

    AGDV

    Peptide fragment of fibrinogen, glycoprotein IIb/I...
    ≥95%
  • A5461

    A-type Natriuretic Peptide (1-30), frog

    Endogenous cardiomodulatory peptide; NPR-A agonist...
    ≥95%
  • D0169

    Darifenacin Hydrobromide

    M3 mAChR antagonist.
    ≥98%
  • W7200

    WS3

    Islet β cell proliferation stimulator.
    ≥98%
  • C2997

    Chymostatin

    Protease inhibitor.
    ≥95% (mixture of A, B, C)
  • C1632

    Cefotaxime Acid

    β-lactam cephalosporin; penicillin binding protei...
    ≥91%
  • V0245

    Valdecoxib

    NSAID; CB1 agonist, COX-2 inhibitor.
    ≥98%
  • T6803

    Trandolapril

    ACE inhibitor.
    ≥98%